Skip Navigation



JAC Advance Access published online on October 24, 2007

Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkm408
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
60/6/1298    most recent
dkm408v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bayston, R.
Right arrow Articles by Freeman, B. J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bayston, R.
Right arrow Articles by Freeman, B. J. C.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection

Roger Bayston1,*, Bryar Nuradeen1, Waheed Ashraf1 and Brian J. C. Freeman2

1 Biomaterials-Related Infection Group, School of Medical and Surgical Sciences, University of Nottingham, Nottingham, UK 2 Centre for Spinal Studies and Surgery, Queen's Medical Centre, University Hospitals NHS Trust, Nottingham, UK

Received 20 June 2007; returned 27 July 2007; revised 1 October 2007; accepted 2 October 2007


* Correspondence address. Biomaterials-Related Infection Group, School of Medical and Surgical Sciences, Division of Orthopaedic and Accident Surgery, C Floor West Block, University Hospitals QMC, Nottingham NG7 2UH, UK. Tel: +44-115-8231115; Fax: +44-115-8231118; E-mail: roger.bayston{at}nottingham.ac.uk

Objectives: Propionibacterium acnes is increasingly recognized as a cause of delayed infection after spinal instrumentation or shunting for hydrocephalus. Biofilm development by this organism has recently been demonstrated. We therefore investigated the effect of two different courses of three antibiotics (penicillin, rifampicin and linezolid) on mature P. acnes biofilms in vitro. Outcomes were eradication or regrowth after withdrawal of antibiotics, simulating successful treatment and relapse.

Methods: P. acnes biofilms were grown on titanium discs for 6 days until mature, then exposed to the antibiotics for either 7 or 14 days before sonication and culture. Further, discs were similarly exposed, but after each course, they were reincubated for a further 9 days to check for regrowth.

Results: Penicillin, linezolid and linezolid plus rifampicin eradicated P. acnes biofilms after 14 days, but only penicillin had this effect after 7 days. ‘Relapse’ was prevented only by 14 day courses of penicillin or linezolid plus rifampicin, but not by linezolid alone.

Conclusions: For P. acnes spinal instrumentation infections, either penicillin or linezolid plus rifampicin might be equally effective. For shunt infections, as penicillin does not give therapeutic cerebrospinal fluid concentrations, rifampicin plus linezolid might be the treatment of choice. Linezolid alone appears not to be as effective as penicillin against P. acnes biofilms.

Key Words: orthopaedic implants , spinal instrumentation , hydrocephalus shunts , P. acnes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.